Inventor · disambiguated record
Christopher Franklin Bigge
Also filed as: BIGGE CHRISTOPHER F · BIGGE CHRISTOPHER FRANKLIN
28 granted patents·7 pending applications·337 citations·filing 1985–2008
97Inventor score
Top patents by PatentIndex Score
35 records- 0191US7030141B2Inhibitors of factor Xa and other serine proteases involved in the coagulation cascadeBIGGE CHRISTOPHER FRANKLIN·Filed 2002·Granted Apr 18, 2006·62 cites·83 claims
- 0286US6218404B1Subtype-selective NMDA receptor ligands and the use thereofWARNER LAMBERT CO·Filed 1996·Granted Apr 17, 2001·33 cites·11 claims
- 0382US6124323A4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonistsWARNER LAMBERT CO·Filed 1996·Granted Sep 26, 2000·54 cites·22 claims
- 0479US5284862ADerivatives of 2-carboxyindoles having pharmaceutical activityWARNER LAMBERT CO·Filed 1992·Granted Feb 8, 1994·21 cites·14 claims
- 0578US6949575B2Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivativesPFIZER·Filed 2001·Granted Sep 27, 2005·14 cites·12 claims
- 0678US6197771B1Glutamate (ampa/kainate) receptor antagonists: N-substituted fused azacycloalkylquinoxalinedionesWARNER LAMBERT CO·Filed 2000·Granted Mar 6, 2001·9 cites·6 claims
- 0777US6972287B1Method of inhibiting amyloid protein aggregation and imaging amyloid depositsPFIZER·Filed 2000·Granted Dec 6, 2005·10 cites·28 claims
- 0875US7407974B2Inhibitors of factor Xa and other serine proteases involved in the coagulation cascadePFIZER·Filed 2005·Granted Aug 5, 2008·1 cites·6 claims
- 0975US6448270B14-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonistsWARNER LAMBERT CO·Filed 2000·Granted Sep 10, 2002·6 cites·17 claims
- 1073US5179085AN-substituted α-amino acids and derivatives thereof having pharmaceutical activityWARNER LAMBERT CO·Filed 1991·Granted Jan 12, 1993·16 cites·6 claims
- 1172US6534522B2Subtype-selective NMDA receptor ligands and the use thereofWARNER LAMBERT CO·Filed 2001·Granted Mar 18, 2003·4 cites·8 claims
- 1270US6696474B2Antidiabetic agentsWARNER LAMBERT CO·Filed 2003·Granted Feb 24, 2004·6 cites·15 claims
- 1370US6124317A2-substituted piperidine analogs and their use as subtype-selective NMDA receptor antagonistsWARNER LAMBERT CO·Filed 1996·Granted Sep 26, 2000·12 cites·13 claims
- 1468US6534525B12-substituted piperidine analogs and their use as subtype-selective NMDA receptor antagonistsWARNER LAMBERT & COMPANY·Filed 2000·Granted Mar 18, 2003·3 cites·12 claims
- 1567US6130234A4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonistsWARNER LAMBERT CO·Filed 1996·Granted Oct 10, 2000·17 cites·16 claims
- 1665US5489717AGlutamate (NMDA) receptor antagonistsWARNER LAMBERT CO·Filed 1994·Granted Feb 6, 1996·8 cites·2 claims
- 1765US2009221546A1Inhibitors of factor xa and other serine proteases involved in the coagulation cascadePFIZER·Filed 2008·Application pending·0 cites
- 1862US2008287674A1Inhibitors of Factor XA and Other Serine Proteases Involved in the Coagulation CascadeBIGGE CHRISTOPHER FRANKLIN·Filed 2008·Application pending·0 cites
- 1961US5942513APharmaceutical composition and a method for treating neurodegenerative diseases using a combination of a kainate excitatory amino acid antagonist and an uricosuric agentWARNER LAMBERT CO·Filed 1998·Granted Aug 24, 1999·12 cites·10 claims
- 2061US5407935APharmaceutical composition for and a method of using a combination of an uricosuric agent and an EAA antagonistWARNER LAMBERT CO·Filed 1993·Granted Apr 18, 1995·10 cites·4 claims
- 2159US5175153ASubstituted alpha-amino acids having pharmaceutical activityWARNER LAMBERT CO·Filed 1988·Granted Dec 29, 1992·9 cites·14 claims
- 2258US5721234AGlutamate receptor antagonists: fused cycloalkylouinoxalinedionesWARNER LAMBERT CO·Filed 1995·Granted Feb 24, 1998·8 cites·13 claims
- 2352US2003105133A14-Substituted piperidine analogs and their use as subtype selective NMDA receptor, antagonistsFiled 2002·Application pending·0 cites
- 2449US2003144319A1Subtype-selective NMDA receptor ligands and the use thereofFiled 2002·Application pending·0 cites
- 2546US5968928AExcitatory amino acid antagonists: fused-azacyclic quinoxalinediones and immunoassays thereofWARNER LAMBERT CO·Filed 1997·Granted Oct 19, 1999·5 cites·9 claims
- 2646US5627168APharmaceutical composition for and a method of using a combination of an uricosuric agent and an EAA antagonistWARNER LAMBERT CO·Filed 1995·Granted May 6, 1997·4 cites·4 claims
- 2745US2004220235A1Method of inhibiting amyloid protein aggregation and imaging amyloid depositsFiled 2004·Application pending·0 cites
- 2844US5668121AGlutamate (NMDA) receptor antagonistsWARNER LAMBERT CO·Filed 1995·Granted Sep 16, 1997·2 cites·14 claims
- 2943US2010029710A1COMPOUNDS HAVING BOTH ANGIOTENSIN II RECEPTOR ANTAGONISM AND PPARy ACTIVATING ACTIVITIESPFIZER PROD INC·Filed 2007·Application pending·0 cites
- 3039US5767119AMethod of treating neurodegenerative diseases using an AMPA excitatory amino and an uricosuric agentWARNER LAMBERT CO·Filed 1996·Granted Jun 16, 1998·2 cites·14 claims
- 3138US6703391B2Quinoxalinedione derivatives, their preparation and useNEUROSEARCH AS·Filed 1995·Granted Mar 9, 2004·2 cites·4 claims
- 3238US5071853APolycyclic amines useful as cerebrovascular agentsBIGGE CHRISTOPHER F·Filed 1990·Granted Dec 10, 1991·5 cites·4 claims
- 3336US4657909AAntimicrobial and antitumor phenazine carboxaldehydes and derivativesWARNER LAMBERT CO·Filed 1985·Granted Apr 14, 1987·2 cites·14 claims
- 3435US2003171377A1Antidiabetic agentsFiled 2002·Application pending·0 cites
- 3531US6057313AGlutamate (ampa/kainate) receptor antagonists: N-substituted fused azacycloalkylquinoxalinedionesWARNER LAMBERT CO·Filed 1997·Granted May 2, 2000·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Christopher Franklin Bigge files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →